Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370290 · ClinicalTrials.gov registry record
Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 74
- Enrollment target
NCT02370290 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 74 participants.
The verdict
NCT02370290 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
This pilot research trial studies quantitative imaging metrics derived from contrast enhanced computed tomography (CECT) in enhancing assessment of disease status in patients with kidney cancer. Quantitative imaging is the extraction of quantifiable features from radiological images for the assessment of disease status. Collecting quantitative imaging metrics from CECT imaging may help doctors predict tumor aggressiveness and nuclear grade (tumor stage) and assess treatment response and prognosis in cancer imaging.
Interventions
- OTHER Medical Chart Review
- OTHER Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02370290
The ClinicalTrials.gov registry entry for NCT02370290 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medical Chart Review is the first listed.
NCT02370290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02370290 about?
NCT02370290 is a clinical study titled "Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer". This pilot research trial studies quantitative imaging metrics derived from contrast enhanced computed tomography (CECT) in enhancing assessment of disease status in patients with kidney cancer. Quantitative imaging is the extraction of quantifiable features from radiological images for the assessme...
What is the current status of trial NCT02370290?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2014-04. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02370290?
The interventions under investigation include: Medical Chart Review (OTHER), Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT02370290?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.